X-Chem is the industry-leading provider of DNA-Encoded Library (DEL)-based discovery services. DEL technology allows customers to screen billions of compounds simultaneously against a single biological target, and is an innovative and high growth segment of the market.
From its US headquarters in Waltham, and leveraging a proprietary DEL platform with libraries containing over 200 billion small molecules, X-Chem has supported drug discovery programmes for partners throughout the US, Europe and Japan and has licensed over seventy research programs to companies, comprising hundreds of novel chemical entities.
